These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21569091)

  • 1. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.
    Kuerten S; Gruppe TL; Laurentius LM; Kirch C; Tary-Lehmann M; Lehmann PV; Addicks K
    APMIS; 2011 Jun; 119(6):336-46. PubMed ID: 21569091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE.
    Kuerten S; Pauly R; Rottlaender A; Rodi M; Gruppe TL; Addicks K; Tary-Lehmann M; Lehmann PV
    Clin Immunol; 2011 Jul; 140(1):54-62. PubMed ID: 21489887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice.
    Kuerten S; Rodi M; Javeri S; Gruppe TL; Tary-Lehmann M; Lehmann PV; Addicks K
    APMIS; 2009 Dec; 117(12):923-35. PubMed ID: 20078558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MBP-PLP fusion protein-induced EAE in C57BL/6 mice.
    Kuerten S; Lichtenegger FS; Faas S; Angelov DN; Tary-Lehmann M; Lehmann PV
    J Neuroimmunol; 2006 Aug; 177(1-2):99-111. PubMed ID: 16781782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
    Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
    J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
    J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
    Recks MS; Addicks K; Kuerten S
    Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.
    Javeri S; Rodi M; Tary-Lehmann M; Lehmann PV; Addicks K; Kuerten S
    Clin Immunol; 2010 Nov; 137(2):181-9. PubMed ID: 20797911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.
    Kuerten S; Javeri S; Tary-Lehmann M; Lehmann PV; Angelov DN
    Clin Immunol; 2008 Nov; 129(2):256-67. PubMed ID: 18722816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
    Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
    Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
    Recks MS; Grether NB; van der Broeck F; Ganscher A; Wagner N; Henke E; Ergün S; Schroeter M; Kuerten S
    Clin Immunol; 2015 Jul; 159(1):93-106. PubMed ID: 25959684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.